Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ECNP 2022 | Major global burden of postpartum depression

Gisèle Apter, MD, PhD, Groupe Hospitalier du Havre, Université de Rouen Normandie, Rouen, France, highlights the prevalence of postpartum depression (PPD) and the major burden that it represents. The impacts of PPD can be long lasting as it not only affects the mother and her relationship with her child, but also has been shown to play a part in the child’s emotional, cognitive, and behavioral development. While prevalence estimates vary, it is thought approximately 16% of new mothers experience PPD, with even higher rates reported in low- and middle-income countries. Given its substantial global burden, Prof. Apter discusses the critical importance of reconstructing current diagnostic and treatment standards which are suboptimal, non-specific, and can feed into the stigma surrounding maternal mental health. This interview took place at the 35th European College of Neuropsychopharmacology (ECNP) Congress 2022 in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Prof. Apter reports the following disclosures: Biogen and Sage Therapeutics consulting board.